# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035165
Filing Date
2024-08-06
Accepted
2024-08-06 16:02:42
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmo-20240630.htm iXBRL | 10-Q | 1071071
2 | EX-31.1 | sgmo-20240630xex311.htm | EX-31.1 | 10020
3 | EX-31.2 | sgmo-20240630xex312.htm | EX-31.2 | 10135
4 | EX-32.1 | sgmo-20240630xex321.htm | EX-32.1 | 7131
| Complete submission text file | 0001628280-24-035165.txt |  | 5465100

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20240630.xsd | EX-101.SCH | 38354
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sgmo-20240630_cal.xml | EX-101.CAL | 58228
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20240630_def.xml | EX-101.DEF | 193108
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20240630_lab.xml | EX-101.LAB | 435009
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20240630_pre.xml | EX-101.PRE | 318462
61 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20240630_htm.xml | XML | 707315

Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 241179020
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)